Home › Cancro alla prostata › Maryland
Studi clinici su Cancro alla prostata nello stato di Maryland
65 studi su Cancro alla prostata cercano partecipanti presso sedi nello stato di Maryland.
Città nello stato di Maryland
Testo ufficiale dello studio (inglese)
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 18 a 120 · Uomini · Aggiornato il 2 ott 2026 · NCT01834001IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 2
Età da 18 a 120 · Uomini · Aggiornato il 2 ott 2026 · NCT07686380Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Upper Chesapeake Medical Center, Bel Air
- e altri 3
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 2 ott 2026 · NCT07200830Collection of Blood From Patients With Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 2 ott 2026 · NCT00923221Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- e altri 10
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età 3 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT01441089A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT03866382Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT00034216Precision-Based Genomics in Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 18 a 120 · Uomini · Aggiornato il 28 set 2026 · NCT04706663Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Chesapeake Urology Associates, Hanover
- Chesapeake Urology Associates, Towson
In reclutamentoStudio osservazionale
Età da 40 a 75 · Uomini · Aggiornato il 28 set 2026 · NCT07543757Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 25 set 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06136650Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 22 set 2026 · NCT05588128Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 22 set 2026 · NCT02594202A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 22 set 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Towson
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 18 set 2026 · NCT06952803A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 18 set 2026 · NCT05361798Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 2
Età da 18 a 120 · Uomini · Aggiornato il 17 set 2026 · NCT05616650A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 17 set 2026 · NCT06925737PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 15 set 2026 · NCT04995198A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- Chesapeake Urology Research Associates, Towson
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 15 set 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Anne Arundel Urology, Annapolis
In reclutamento
Età 18 e oltre · Uomini · Aggiornato il 14 set 2026 · NCT06511141Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- e altri 7
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 10 set 2026 · NCT05946213Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 8 set 2026 · NCT03354416Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 2
Età da 18 a 120 · Uomini · Aggiornato il 3 set 2026 · NCT06096870Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06138067Men at High Genetic Risk for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoStudio osservazionale
Età da 30 a 75 · Uomini · Aggiornato il 3 set 2026 · NCT03805919A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 1/2
Età da 18 a 110 · Uomini · Aggiornato il 3 set 2026 · NCT04633252The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
In reclutamentoVolontari sani benvenuti
Età da 45 a 75 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06995898Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamento
Età 18 e oltre · Uomini · Aggiornato il 27 ago 2026 · NCT04692675Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- Johns Hopkins Hospital, Baltimore
In reclutamento
Età da 45 a 75 · Uomini · Aggiornato il 26 ago 2026 · NCT02871726Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Maryland Greenebaum Cancer Center, Baltimore
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 24 ago 2026 · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Johns Hopkins Hospital, Baltimore
In reclutamentoFase 1/2
Età 18 e oltre · Uomini · Aggiornato il 20 ago 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- Suburban Hospital, Bethesda
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 19 ago 2026 · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
In reclutamentoFase 1
Età da 18 a 100 · Uomini · Aggiornato il 13 ago 2026 · NCT05519449Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Johns Hopkins University, Baltimore
In reclutamentoStudio osservazionale
Età 18 e oltre · Uomini · Aggiornato il 12 ago 2026 · NCT04489719Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
In reclutamentoFase 2
Età da 18 a 120 · Uomini · Aggiornato il 24 lug 2026 · NCT06161506Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- Christiana Care - Union Hospital, Elkton
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 14 lug 2026 · NCT06592924Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.